Table of contents

01 Pre-meeting briefing

02 Company submission - Merck Sharp & Dohme

03 Company submission - risk analysis - Merck Sharp & Dohme

04 NICE clarification Letter

05 Company response to the NICE clarification letter

06 Company response to the NICE clarification letter – erratum

07 Professional group submission - NCRI/RCP/RCR/ACP and Melanoma Focus

08 Expert written personal statement - Louise Fearfield

09 Expert written personal statement - Pippa Corrie

10 Expert written personal statement - Gillian Nuttall

11 Expert written personal statement - Kathryn Silvester-Eccles

12 Evidence Review Group report

13 Evidence Review Group report – factual accuracy check

14 Erratum to the ERG report